---

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

---

 

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

---

 

Date of report (Date of earliest event reported): October 21, 2003

 

 

CARDIAC SCIENCE, INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

 

1900 Main Street, Suite 700

Irvine, CA 92614

(Address of Principal Executive Offices and Zip Code)

 

Registrant’s telephone number, including area code:

(949) 797-3800

 

---

---

ITEM 5.    OTHER EVENTS AND REGULATION FD DISCLOSURE

 

On October 21, 2003, Cardiac Science, Inc., issued a press release announcing the acquisition by Cardiac Science of substantially all of the assets of Complient Corporation. As consideration, Cardiac Science issued to Complient 10.25 million shares of its common stock, subject to certain restrictions.

 

A copy of the press release is attached hereto as Exhibit 99.1.

 

ITEM 7.    Financial Statements, Pro Forma Financial Information and Exhibits

 

(c)    Exhibits:

 

 

---

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

CARDIAC SCIENCE, INC.

 

By: /s/ Raymond W. Cohen

Raymond W. Cohen,

President and Chief Executive Officer

 

Dated: October 21, 2003